Minute Insight: Illumina Seeks Stability, Names Thaysen As New CEO
The genome-sequencing giant has named Jacob Thaysen, who brings extensive experience from Agilent, as its new leader.
You may also be interested in...
Illumina sued Guardant last year, claiming Guardant’s founders stole trade secrets related to blood biopsy diagnostics. The companies have agreed to drop that dispute and share specimen samples for cancer research.
The sequencing giant could be pilloried in Europe and may have to pay a record-breaking fine.
Francis deSouza resigned as CEO and chairman of Illumina just a few weeks after winning the support of shareholders. General counsel Charles Dadswell will take over as interim CEO.